Non-dilutive federal funding will support preclinical and clinical work validating red blood cell-bound tumor DNA as an early ...

Sept 29 (Reuters) - HUTCHMED (China) said on Tuesday that Anglo-Swedish drugmaker AstraZeneca had applied to the US Food and ...

The inherited mutation substantially increases the chance of developing lung cancer, including in people who don't smoke.

Never-smokers carrying the rare EGFR T790M gene variant face 62 times the odds of lung cancer, a major study of 3.3 million ...

C EGFR T790M gene variant face roughly 25 times the lung cancer risk of noncarriers, according to the largest-yet study of ...

Lung cancer is still the top cancer killer, but new developments are shifting what the future might hold for patients.

Lung cancer incidence decreased 3.5%/year in males and 1.9%/year in females during 2018–2022, alongside a two-thirds increase ...

Merck paid Daiichi $4 billion upfront in 2023 to partner on three ADCs. The FDA rejected a request for approval of one of the ...

LUNGevity Foundation, the nation's leading lung cancer–focused nonprofit organization, today announced its support of two innovative and ambitious research projects designed to fundamentally change ...

Dartmouth Cancer Center joins a statewide push to raise lung cancer screening rates, as only 31.1% of eligible New Hampshire ...

One rare inherited mutation raised lung cancer risk more than smoking did, and the effect was strongest in people who never ...